Drug Makers Eye Jump In Generics Sales Due To Japan Rules Change
This article was originally published in PharmAsia News
Executive Summary
Generic drugs sales in Japan are expected to take off as a result of a recent regulatory change, and local drug makers are seeking local alliances and other changes to take advantage of what they see as a large sales potential.